Margolis B, Rhee S G, Felder S, Mervic M, Lyall R, Levitzki A, Ullrich A, Zilberstein A, Schlessinger J
Rorer Biotechnology, Inc., King of Prussia, Pennsylvania 19406.
Cell. 1989 Jun 30;57(7):1101-7. doi: 10.1016/0092-8674(89)90047-0.
Binding of EGF to cells expressing human EGF receptor stimulated rapid tyrosine phosphorylation of phospholipase C-II (PLC-II), as revealed by immunoblotting analysis with phosphotyrosine-specific antibodies. Tyrosine phosphorylation of PLC-II was stimulated by low physiological concentrations of EGF (1 nM), was quantitative, and was already maximal after a 30 sec incubation with 50 nM EGF at 37 degrees C. Interestingly, antibodies specific for PLC-II were able to coimmunoprecipitate the EGF receptor and antibodies against EGF receptor also coimmunoprecipitated PLC-II. According to this analysis, approximately 1% of EGF receptor molecules were associated with PLC-II molecules. The protein tyrosine kinase inhibitor tyrphostin RG50864, which blocks EGF-dependent cell proliferation, blocked EGF-induced tyrosine phosphorylation of PLC-II, its association with EGF receptor, and EGF-induced Ca2+ release. Hence, EGF-induced tyrosine phosphorylation of PLC-II may be a regulatory event linking the tyrosine kinase activity of EGF receptor to the PIP2 hydrolysis signaling pathway.
用磷酸酪氨酸特异性抗体进行免疫印迹分析表明,表皮生长因子(EGF)与表达人EGF受体的细胞结合,可刺激磷脂酶C-II(PLC-II)快速发生酪氨酸磷酸化。低生理浓度(1 nM)的EGF即可刺激PLC-II的酪氨酸磷酸化,且呈定量关系,在37℃下与50 nM EGF孵育30秒后,酪氨酸磷酸化已达最大值。有趣的是,针对PLC-II的特异性抗体能够共免疫沉淀EGF受体,而针对EGF受体的抗体也能共免疫沉淀PLC-II。根据该分析,约1%的EGF受体分子与PLC-II分子相关联。蛋白酪氨酸激酶抑制剂 tyrphostin RG50864可阻断EGF依赖的细胞增殖,它能阻断EGF诱导的PLC-II酪氨酸磷酸化、其与EGF受体的结合以及EGF诱导的Ca2+释放。因此,EGF诱导的PLC-II酪氨酸磷酸化可能是一个将EGF受体的酪氨酸激酶活性与磷脂酰肌醇-4,5-二磷酸(PIP2)水解信号通路相联系的调节事件。